Related Experiment Video
Updated: Jul 22, 2026

00:13
Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
Published on: September 28, 2019
7.4K
Predicting the unpredictable: a robust nomogram for predicting recurrence in patients with ampullary carcinoma
Ruiqiu Chen1,2,3, Lin Zhu1,2,3, Yibin Zhang4
1Medical School of Chinese PLA, Beijing, China.
BMC Cancer
|February 15, 2024
Summary
This study identifies key risk factors for ampullary carcinoma recurrence after surgery. A robust Lasso-Cox regression model and nomogram were developed for accurate recurrence risk prediction in patients.
Area of Science:
- Oncology
- Surgical Oncology
- Biostatistics
Background:
- Ampullary carcinoma (AC) is a rare malignancy requiring effective recurrence risk assessment post-resection.
- Identifying predictive factors is crucial for personalized patient management and improved outcomes.
Purpose of the Study:
- To identify risk factors influencing recurrence in ampullary carcinoma patients after radical resection.
- To develop and validate a predictive model for AC recurrence using Lasso-Cox regression.
Main Methods:
- Retrospective analysis of 162 ampullary carcinoma patients undergoing pancreaticoduodenectomy.
- Lasso regression for risk factor screening, followed by Lasso-Cox regression and Random Survival Forest (RSF) model comparison.
- Model validation using time-dependent ROC curves, calibration plots, and decision curve analysis (DCA).
Main Results:
- Lasso regression identified CA19-9/GGT, TNM staging, lymph node invasion, differentiation, tumor size, CA19-9, gender, GPR, PLR, drinking history, and complications as significant factors.
- The Lasso-Cox regression model demonstrated superior predictive performance (C-index=0.845) compared to RSF (C-index=0.719).
- The validated model showed high accuracy across 1, 3, and 5-year prediction intervals, with excellent calibration and broad clinical utility via DCA.
Conclusions:
- A robust nomogram based on Lasso-Cox regression effectively predicts recurrence in ampullary carcinoma patients.
- This developed model offers enhanced accuracy and reliability for clinical risk stratification compared to other methods.

